Your browser doesn't support javascript.
loading
Favorable survival outcomes in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer sequentially treated with a tyrosine kinase inhibitor and osimertinib in a real-world setting.
Kraskowski, Oliver; Stratmann, Jan A; Wiesweg, Marcel; Eberhardt, Wilfried; Metzenmacher, Martin; Schmid, Kurt W; Herold, Thomas; Schildhaus, Hans-Ulrich; Darwiche, Kaid; Aigner, Clemens; Stuschke, Martin; Laue, Katharina; Zaun, Gregor; Kasper, Stefan; Hense, Jörg; Sebastian, Martin; Schuler, Martin; Pogorzelski, Michael.
Afiliação
  • Kraskowski O; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Stratmann JA; Department of Internal Medicine, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany.
  • Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Eberhardt W; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Metzenmacher M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Schmid KW; Institute of Pathology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Herold T; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Schildhaus HU; Institute of Pathology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Darwiche K; Institute of Pathology, West German Cancer Center, University Hospital Essen, Essen, Germany.
  • Aigner C; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Stuschke M; Section of Interventional Pneumology, Department of Pneumology, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, Essen, Germany.
  • Laue K; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Zaun G; Department of Thoracic Surgery and Surgical Endoscopy, West German Cancer Center, University Medicine Essen-Ruhrlandklinik, Essen, Germany.
  • Kasper S; German Cancer Consortium (DKTK), Partner Site University Hospital Essen, Essen, Germany.
  • Hense J; Department of Radiation Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Sebastian M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
  • Pogorzelski M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Hufelandstr. 55, 46147, Essen, Germany.
J Cancer Res Clin Oncol ; 149(11): 9243-9252, 2023 Sep.
Article em En | MEDLINE | ID: mdl-37198447
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans / Middle aged Idioma: En Ano de publicação: 2023 Tipo de documento: Article